BioWorld

Nov. 22, 2002

View Archived Issues

Lundbeck Acquiring Synaptic, CNS Pipeline For $121M In Cash

Synaptic Pharmaceutical Corp. signed a definitive merger agreement with like-minded central nervous system-focused H. Lundbeck A/S in a deal worth about $121 million. (BioWorld Today) Read More

Jun Gene Encodes Enzyme That Links Obesity, Diabetes In Tissue Inflammation With Drug Designs

Read More

Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis

Read More

Other News To Note

Read More

Inflazyme In Line For Up To $90M After Expanding Deal With Aventis

Read More